Stay updated on ASCT With Nivolumab in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the ASCT With Nivolumab in Multiple Myeloma Clinical Trial page.

Latest updates to the ASCT With Nivolumab in Multiple Myeloma Clinical Trial page
- CheckyesterdayChange DetectedThe page now includes new related topics: 'Multiple myeloma' and a link/reference to 'MedlinePlus Genetics', expanding the disease focus context and providing an accessible genetics resource.SummaryDifference0.2%

- Check8 days agoChange DetectedThe page’s revision/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a minor site update rather than a change to the clinical trial details.SummaryDifference0.1%

- Check15 days agoChange DetectedAdded Revision: v3.5.2. Removed references to Multiple Myeloma and related topics (MedlinePlus Genetics) and noted Revision: v3.5.0.SummaryDifference0.2%

- Check22 days agoNo Change Detected
- Check44 days agoChange DetectedAdded 'Multiple myeloma' as a related topic and linked 'MedlinePlus Genetics'. The site revision was updated from 3.4.3 to 3.5.0.SummaryDifference0.2%

- Check51 days agoChange DetectedThe page now displays a new revision label: v3.4.3, replacing the previous v3.4.2.SummaryDifference0.1%

- Check80 days agoChange DetectedA new site revision was added (v3.4.2) and the older entry (v3.4.1) was removed; a government funding notice shown previously is no longer present. No study content, eligibility criteria, or results were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to ASCT With Nivolumab in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ASCT With Nivolumab in Multiple Myeloma Clinical Trial page.